Electroconvulsive therapy (ECT) does not increase the risk of developing dementia. A systematic review and meta-analysis of long-term outcomes found no statistically significant association between ECT and dementia risk, with a hazard ratio of 0.98, meaning the risk was essentially identical to that of similar patients who never received ECT. In adults over 50, ECT was actually associated with a 22% lower risk of dementia compared to those who didn’t receive it.
This is one of the most common concerns people have about ECT, and it makes sense. The treatment does cause short-term memory disruption, and for decades, outdated portrayals of the procedure fueled fears about lasting brain damage. Here’s what the evidence actually shows.
What Large Studies Have Found
The strongest evidence comes from population-level studies that tracked thousands of patients over years. A nationwide cohort study using Taiwan’s health insurance database compared patients who received ECT for schizophrenia, bipolar disorder, or major depression against matched controls who didn’t. Of the ECT patients, 4.53% developed dementia over the follow-up period, compared to 5.0% in the control group. After adjusting for age, sex, income, location, and other health conditions, there was no increased dementia risk. A separate Danish cohort study reached the same conclusion for patients with mood disorders.
The most comprehensive analysis pooled data from multiple studies and graded the certainty of evidence. The overall finding was clear: ECT exposure carried no additional dementia risk. For older adults specifically (over 50, across more than 112,000 patients), the data pointed toward a protective effect. That finding held with no statistical inconsistency between studies, earning a moderate certainty rating.
Why might ECT appear protective in older adults? The most likely explanation involves what it treats. Severe, untreated depression is itself a significant risk factor for dementia. Successfully treating that depression, which ECT does effectively when medications fail, may reduce the cumulative toll that chronic mood disorders take on the brain.
ECT’s Short-Term Memory Effects
ECT does affect memory in the short term, and this is likely where much of the dementia concern originates. The two main types of memory disruption are distinct and follow different timelines.
The first is difficulty forming new memories. Your ability to learn and retain new information dips immediately after treatment. Meta-analyses show that this ability returns to baseline within about two weeks of completing a course of ECT. One study measuring multiple memory domains (immediate recall, delayed recall, working memory) found that scores not only recovered by four weeks after the final session but actually exceeded pre-treatment levels, likely because the depression itself had been impairing cognition.
The second type is loss of autobiographical memories, meaning personal experiences from before or during the treatment period. This is the side effect patients report most often, and it’s more variable. Some memories from the weeks surrounding treatment may not return. Objective testing shows this loss can persist beyond a year and exceeds the normal fading of memories over time. However, autobiographical memory gaps from a specific period are fundamentally different from dementia, which involves progressive, worsening decline across all cognitive domains.
What Happens to the Brain During ECT
Rather than causing brain atrophy, ECT appears to do the opposite in a key brain region. Multiple neuroimaging studies have shown that ECT increases hippocampal volume, the part of the brain most involved in memory formation. One study measured an average increase from about 6,794 cubic millimeters to 6,979 cubic millimeters after a treatment course.
This growth likely results from several overlapping biological processes: the formation of new brain cells, new supportive cells, new connections between neurons, and new blood vessels. Growth factors in the brain, particularly those involved in building blood vessels and supporting nerve cells, appear to drive these changes. This pattern of hippocampal growth is the opposite of what you’d see in a process leading to dementia, where the hippocampus shrinks progressively over time.
How Treatment Technique Affects Side Effects
Not all ECT is delivered the same way, and the approach your treatment team uses significantly affects cognitive side effects. Two variables matter most: where the electrodes are placed and how long each electrical pulse lasts.
Electrode placement on only the right side of the head (called right unilateral placement) produces fewer memory side effects than placement on both sides. The second variable is pulse width. Modern ECT increasingly uses “ultrabrief” pulses lasting about 0.3 milliseconds, compared to older “brief” pulses of 0.5 to 2.0 milliseconds. Randomized trials have shown that ultrabrief-pulse treatment causes less cognitive impairment both after individual sessions and across the full treatment course. Patients in ultrabrief groups reoriented faster after each session, recalled words better, and lost fewer autobiographical memories.
If cognitive side effects are a concern for you, it’s worth asking your treatment team about right unilateral placement with ultrabrief pulse width. This combination represents the most cognitively gentle approach currently available.
Depression Itself Is the Bigger Risk Factor
One of the most important things to understand about this question is that the conditions ECT treats, particularly severe and treatment-resistant depression, carry their own substantial dementia risk. Depression impairs concentration, memory, and processing speed so significantly that it’s sometimes mistaken for early dementia (a phenomenon called “pseudodementia”). Chronic, recurring depression also appears to accelerate genuine cognitive decline over decades.
This creates a confounding problem in research: people who receive ECT tend to have the most severe, treatment-resistant forms of mental illness. If they develop dementia at higher rates than the general population, it may reflect the underlying disease rather than the treatment. The fact that studies adjusting for these factors still find no increased risk from ECT, and in some cases find a reduced risk, is reassuring. It suggests that effectively treating severe depression may be more protective for long-term brain health than avoiding ECT out of fear of cognitive harm.
What Recovery Looks Like
A standard course of ECT involves about 6 to 12 sessions. During this period, you can expect some fogginess and difficulty retaining new information, particularly on treatment days. Most people notice this lifting within the first two weeks after their final session. By six months, reviews of the evidence agree that no measurable cognitive deficits persist compared to baseline or compared to people treated with medication alone.
The exception is the autobiographical memory gaps mentioned earlier. You may permanently lose some memories from the period surrounding treatment, and occasionally from weeks or months before it began. These gaps tend to improve substantially over six months but may not fully resolve. For most people, this represents a specific, bounded loss rather than an ongoing decline, which is the hallmark distinction between a side effect of treatment and a neurodegenerative disease like dementia.